Brian Pan

BrianPan-headshot

BioHealthWays, Inc.

2016-2017

Affiliations

State University of New York

Technologies

Medical Device

Indication

Ophthalmology

Executive Summary

View/Download

BioHealthWays prevents vision loss by delivering biologics in the eye. Our implant drastically reduces injections and improves compliance & convenience. The target market is $7B+, with 12M Americans having retinal neovascular conditions.

Newsletter Signup

Corporate Supporters

Community Service Providers